TITLE

Effect of antibiotic treatment on inflammatory markers and lung function in cystic fibrosis patients with Pseudomonas cepacia

AUTHOR(S)
Peckham, D; Crouch, S; Humphreys, H; Lobo, B; Tse, A; Knox, A J
PUB. DATE
August 1994
SOURCE
Thorax;Aug1994, Vol. 49 Issue 8, p803
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
66124166

 

Related Articles

  • Azithromycin reduces spontaneous and induced inflammation in ΔF508 cystic fibrosis mice. Legssyer, Rachida; Huaux, François; Lebacq, Jean; Delos, Monique; Marbaix, Etienne; Lebecque, Patrick; Lison, Dominique; Scholte, Bob J.; Wallemacq, Pierre; Leal, Teresinha // Respiratory Research;2006, Vol. 7, p134 

    Background: Inflammation plays a critical role in lung disease development and progression in cystic fibrosis. Azithromycin is used for the treatment of cystic fibrosis lung disease, although its mechanisms of action are poorly understood. We tested the hypothesis that azithromycin modulates...

  • Inhaled tobramycin improves lung function and bacterial density associated with Pseudomonas aeruginosa infections in patients with cystic fibrosis. Adis International Limited // Drugs & Therapy Perspectives;Sep2004, Vol. 20 Issue 9, p1 

    Focuses on the effects of inhaled tobramycin on lung function and bacterial density associated with Pseudomonas aeruginosa infections in cystic fibrosis patients. Clinical benefits and potential limitations of tobramycin solution for inhalation (TSI) in the management of Pseudomonas aeruginosa...

  • The spectrum of cystic fibrosis exacerbations.  // Thorax;Dec2006 Supplement 2, Vol. 61, pii33 

    The article presents abstracts of medical research related to the spectrum of cystic fibrosis exacerbations. They include "Characterization of Bacterial Diversity in Cystic Fibrosis Sputum," "Outcome of Burkholderia Cepacia Complex Pulmonary Infection in Patients with Cystic Fibrosis from...

  • Prospects for the Prevention and Control of Pseudomonal Infection in Children with Cystic Fibrosis. Høiby, N. // Pediatric Drugs;Nov/Dec2000, Vol. 2 Issue 6, p451 

    Most patients with cystic fibrosis (CF) experience recurrent and chronic endobronchial Pseudomonas aeruginosa infections. It is possible to prevent or delay the onset of these chronic infections in most patients with CF by eliminating cross-infection and by early aggressive antibiotic treatment...

  • In Vivo Fluorescence Imaging of Bacteriogenic Cyanide in the Lungs of Live Mice Infected with Cystic Fibrosis Pathogens. Seong-Won Nam; Xiaoqiang Chen; Jeesun Lim; So Hyun Kim; Sang-Tae Kim; You-Hee Cho; Juyoung Yoon; Sungsu Park // PLoS ONE;2011, Vol. 6 Issue 7, p1 

    Background: Pseudomonas aeruginosa (PA) and Burkholderia cepacia complex (Bcc), commonly found in the lungs of cystic fibrosis (CF) patients, often produce cyanide (CN), which inhibits cellular respiration. CN in sputa is a potential biomarker for lung infection by CF pathogens. However, its...

  • The Role of Macrolides in Childhood Non-Cystic Fibrosis-Related Bronchiectasis. Masekela, R.; Green, R. J. // Mediators of Inflammation;2012, Vol. 2012, p1 

    Non-cystic fibrosis-related bronchiectasis is a chronic inflammatory lung disease, which is regarded as an "orphan" lung disease, with little research devoted to the study of this condition. Bronchiectasis results in impaired quality of life and mortality if left untreated. The tools available...

  • Aminoglycosides, toxicity and cystic fibrosis. Watson, Alan R. // Journal of the Royal Society of Medicine (Supplement);Jun2007, Vol. 100 Issue 47, p24 

    The article focuses on the use of aminoglycosides for the treatment of cystic fibrosis. Aminoglycosides are active against Pseudomonas aeruginosa and synergizes with beta lactum antibiotics which effectively penetrate the sputum. It also discusses why there is little concern about nephrotoxicity...

  • Mechanisms of cystic fibrosis.  // Thorax;Dec2013 Supplement, Vol. 68 Issue S3, pA53 

    The article presents abstracts on topics related to cystic fibrosis (CF) mechanisms including T-helper cell response against Pseudomonas aeruginosa in cystic fibrosis patients, functional variant of protein Elafin with anti-inflammatory activity, and respiratory viruses' effect on CF patients.

  • Agricultural use of Burkholderia (Pseudomonas) cepacia: a threat to human health? Holmes, Alison; Govan, John; Goldstein, Richard; Holmes, A; Govan, J; Goldstein, R // Emerging Infectious Diseases;Apr-Jun98, Vol. 4 Issue 2, p221 

    In the past 2 decades, Burkholderia cepacia has emerged as a human pathogen causing numerous outbreaks, particularly among cystic fibrosis (CF) patients. One highly transmissible strain has spread across North America and Britain, and another between hospitalized CF and non-CF patients....

  • Combination antibiotic susceptibility of biofilm-grown Burkholderia cepacia and Pseudomonas aeruginosa isolated from patients with pulmonary exacerbations of cystic fibrosis. Dales, L.; Ferris, W.; Vandemheen, K.; Aaron, S. D. // European Journal of Clinical Microbiology & Infectious Diseases;Oct2009, Vol. 28 Issue 10, p1275 

    We identified double and triple antibiotic combinations effective against biofilm-grown Burkholderia cepacia and Pseudomonas aeruginosa sampled from cystic fibrosis (CF) patients undergoing acute pulmonary exacerbations. Sputum bacteria from 110 CF patients were grown as biofilms. Combination...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics